rs13879

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001848.3(COL6A1):​c.2736C>T​(p.Asp912=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0264 in 1,613,080 control chromosomes in the GnomAD database, including 690 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 49 hom., cov: 35)
Exomes 𝑓: 0.027 ( 641 hom. )

Consequence

COL6A1
NM_001848.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -1.37
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 21-46003662-C-T is Benign according to our data. Variant chr21-46003662-C-T is described in ClinVar as [Benign]. Clinvar id is 93866.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-46003662-C-T is described in Lovd as [Benign]. Variant chr21-46003662-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-1.37 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0201 (3060/152366) while in subpopulation NFE AF= 0.0305 (2076/68036). AF 95% confidence interval is 0.0294. There are 49 homozygotes in gnomad4. There are 1431 alleles in male gnomad4 subpopulation. Median coverage is 35. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 49 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL6A1NM_001848.3 linkuse as main transcriptc.2736C>T p.Asp912= synonymous_variant 35/35 ENST00000361866.8 NP_001839.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL6A1ENST00000361866.8 linkuse as main transcriptc.2736C>T p.Asp912= synonymous_variant 35/351 NM_001848.3 ENSP00000355180 P1

Frequencies

GnomAD3 genomes
AF:
0.0201
AC:
3061
AN:
152248
Hom.:
49
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.00600
Gnomad AMI
AF:
0.0811
Gnomad AMR
AF:
0.0201
Gnomad ASJ
AF:
0.0403
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00993
Gnomad FIN
AF:
0.0110
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0305
Gnomad OTH
AF:
0.0224
GnomAD3 exomes
AF:
0.0203
AC:
5046
AN:
248808
Hom.:
75
AF XY:
0.0206
AC XY:
2781
AN XY:
135144
show subpopulations
Gnomad AFR exome
AF:
0.00429
Gnomad AMR exome
AF:
0.0126
Gnomad ASJ exome
AF:
0.0364
Gnomad EAS exome
AF:
0.000221
Gnomad SAS exome
AF:
0.00762
Gnomad FIN exome
AF:
0.0125
Gnomad NFE exome
AF:
0.0316
Gnomad OTH exome
AF:
0.0218
GnomAD4 exome
AF:
0.0270
AC:
39453
AN:
1460714
Hom.:
641
Cov.:
62
AF XY:
0.0266
AC XY:
19361
AN XY:
726678
show subpopulations
Gnomad4 AFR exome
AF:
0.00376
Gnomad4 AMR exome
AF:
0.0140
Gnomad4 ASJ exome
AF:
0.0379
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.00817
Gnomad4 FIN exome
AF:
0.0128
Gnomad4 NFE exome
AF:
0.0312
Gnomad4 OTH exome
AF:
0.0253
GnomAD4 genome
AF:
0.0201
AC:
3060
AN:
152366
Hom.:
49
Cov.:
35
AF XY:
0.0192
AC XY:
1431
AN XY:
74508
show subpopulations
Gnomad4 AFR
AF:
0.00599
Gnomad4 AMR
AF:
0.0200
Gnomad4 ASJ
AF:
0.0403
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00993
Gnomad4 FIN
AF:
0.0110
Gnomad4 NFE
AF:
0.0305
Gnomad4 OTH
AF:
0.0222
Alfa
AF:
0.0273
Hom.:
32
Bravo
AF:
0.0195
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0317
EpiControl
AF:
0.0357

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 12, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 23, 2012- -
not provided Benign:2
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Ullrich congenital muscular dystrophy 1A;CN029274:Bethlem myopathy 1A Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 31, 2017- -
Bethlem myopathy 1A Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.79
DANN
Benign
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs13879; hg19: chr21-47423576; COSMIC: COSV62612335; COSMIC: COSV62612335; API